PTEN promoter methylation and protein expression in normal early placentas and hydatidiform moles

Journal of the Society for Gynecologic Investigation

Volumn 12, Issue 3, 2005, Pages 214-217

  Chen, Huaizeng ^a   Ye, Dafeng ^a   Xie, Xing ^a,b   Lu, Weiguo ^a   Zhu, Changkun ^a   Chen, Xiaodong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Gestational trophoblastic disease; Promoter methylation; PTEN; Trophoblasts

Indexed keywords

ENDONUCLEASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; ENZYMATIC DEGRADATION; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TROPHOBLAST;

DNA METHYLATION; FEMALE; HUMANS; HYDATIDIFORM MOLE; PHOSPHORIC MONOESTER HYDROLASES; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROMOTER REGIONS (GENETICS); PTEN PHOSPHOHYDROLASE; REFERENCE VALUES; TUMOR SUPPRESSOR PROTEINS;

EID: 15244355897     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2005.01.009     Document Type: Article

References (24)

1. J. Li, C. Yen, D. Liaw PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
2. M.P. Myers, J.P. Stolarov, C. Eng P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase Proc Natl Acad Sci U S A 94 1997 9052 9057
3. A. Suzuki, J.L. de la Pompa, V. Stambolic High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice Curr Biol 8 1998 1169 1178
4. S. Pianetti, M. Arsura, R. Romieu-Mourez, R.J. Coffey, G.E. Sonenshein Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN Oncogene 20 2001 1287 1299
5. J.M. Paramio, M. Navarro, C. Segrelles, E. Gomez-Casero, J.L. Jorcano PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein Oncogene 18 1999 7462 7468
6. M. Tamura, J. Gu, T. Takino, K.M. Yamada Tumor suppressor PTEN inhibition of cell invasion, migration, and growth Differential involvement of focal adhesion kinase and p130Cas Cancer Res 59 1999 442 449
7. L. Nadav, B.Z. Katz The molecular effects of oncogenesis on cell-extracellular matrix adhesion Int J Oncol 19 2001 237 246
8. P.H. Hwang, H.K. Yi, D.S. Kim, S.Y. Nam, J.S. Kim, D.Y. Lee Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene Cancer Lett 172 2001 83 91
9. P. Guldberg, P. Thor Straten, A. Birck, V. Ahrenkiel, A.F. Kirkin, J. Zeuthen Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma Cancer Res 57 1997 3660 3663
10. H. Tashiro, M.S. Blazes, R. Wu Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies Cancer Res 57 1997 393539 393540
11. H.B. Salvesen, N. MacDonald, A. Ryan PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma Int J Cancer 91 2001 22 26
12. Y.H. Kang, H.S. Lee, W.H. Kim Promoter methylation and silencing of PTEN in gastric carcinoma Lab Invest 82 2002 285 291
13. M.F. Kane, M. Loda, G.M. Gaida Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines Cancer Res 57 1997 808 811
14. J. Torres, S. Navarro, I. Rogla Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues Eur J Cancer 37 2001 114 121
15. F.B. Fromowitz, M.V. Viola, S. Chao ras p21 expression in the progression of breast cancer Hum Pathol 18 1987 1268 1275
16. P.L. Dahia PTEN, a unique tumor suppressor gene Endocr Relat Cancer 7 2000 115 129
17. J. McGrath, D. Solter Completion of mouse embryogenesis requires both the maternal and paternal genomes Cell 37 1982 179 183
18. I. Ariel, N. de Groot, A. Hochberg Imprinted H19 gene expression in embryogenesis and human cancer The oncofetal connection Am J Med Genet 91 2000 46 50
19. C. Walsh, S.J. Miller, F. Flam, R.A. Fisher, R. Ohlsson Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast Cancer Res 55 1995 1111 1116
20. M.J. Steenman, S. Rainier, C.J. Dobry Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour Nat Genet 7 1994 433 439
21. I. Ariel, O. Lustig, C.E. Oyer Relaxation of imprinting in trophoblastic disease Gynecol Oncol 53 1994 212 219
22. Z.S. Tuncer, G.L. Vegh, V. Fulop, D.R. Genest, S.C. Mok, R.S. Berkowitz Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor Gynecol Oncol 77 2000 389 393
23. V. Stambolic, D. MacPherson, D. Sas Regulation of PTEN transcription by p53 Mol Cell 8 2001 317 325
24. V. Persaud, P. Ganjei, M. Nadji Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease West Indian Med J 42 1993 142 143